메뉴 건너뛰기




Volumn 29, Issue 5, 2011, Pages 403-414

Cost effectiveness of budesonide/formoterol added to tiotropium bromide versus placebo added to tiotropium bromide in patients with chronic obstructive pulmonary disease: Australian, Canadian and Swedish healthcare perspectives

Author keywords

Budesonideformoterol therapeutic use; Chronic obstructive pulmonary disease treatment; Cost effectiveness; Terbutaline therapeutic use; Tiotropium bromide therapeutic use

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; GLUCOCORTICOID; HANDIHALER; PLACEBO; TERBUTALINE; TIOTROPIUM BROMIDE; TURBUHALER; UNCLASSIFIED DRUG;

EID: 79955053637     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11590380-000000000-00000     Document Type: Article
Times cited : (19)

References (38)
  • 1
    • 69749090917 scopus 로고    scopus 로고
    • WHO [online]. Available from URL:
    • WHO. COPD: burden [online]. Available from URL: http:// www.who.int/respiratory/copd/burden/en/ [Accessed 2010 Mar 1]
    • COPD: Burden
  • 3
    • 39049095704 scopus 로고    scopus 로고
    • The cost of moderate and severe COPD exacerbations to the Canadian healthcare system
    • Mittmann N, Kuramoto L, Seung SJ, et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med 2008; 102 (3): 413-21
    • (2008) Respir Med , vol.102 , Issue.3 , pp. 413-21
    • Mittmann, N.1    Kuramoto, L.2    Seung, S.J.3
  • 4
    • 0013404759 scopus 로고    scopus 로고
    • Canadian Institute for Health Information [online]. Available from URL:
    • Canadian Institute for Health Information. Respiratory disease in Canada [online]. Available from URL: http:// www.phac-aspc.gc.ca/publicat/rdc-mrc01/ pdf/rdc0901e.pdf [Accessed 2010 Mar 1]
    • Respiratory Disease in Canada
  • 6
    • 0037336007 scopus 로고    scopus 로고
    • Costs of chronic bronchitis and COPD: A 1-year follow-up study
    • DOI 10.1378/chest.123.3.784
    • Miravitlles M, Murio C, Guerrero T, et al. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest 2003; 123 (3): 784-91 (Pubitemid 36315494)
    • (2003) Chest , vol.123 , Issue.3 , pp. 784-791
    • Miravitlles, M.1    Murio, C.2    Guerrero, T.3    Gisbert, R.4
  • 10
    • 33645116728 scopus 로고    scopus 로고
    • Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD
    • van Noord JA, Aumann JL, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006; 129 (3): 509-17
    • (2006) Chest , vol.129 , Issue.3 , pp. 509-17
    • Van Noord, J.A.1    Aumann, J.L.2    Janssens, E.3
  • 11
    • 24644492301 scopus 로고    scopus 로고
    • Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: A randomized trial
    • Niewoehner DE, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 2005; 143 (5): 317-26
    • (2005) Ann Intern Med , vol.143 , Issue.5 , pp. 317-26
    • Niewoehner, D.E.1    Rice, K.2    Cote, C.3
  • 13
    • 4644253835 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence (Clinical Guideline 12). London: NICE [online]. Available from URL:
    • National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease (Clinical Guideline 12). London: NICE, 2004 [online]. Available from URL: http://www.nice.org.uk/nicemedia/pdf/CG012- niceguide line.pdf [Accessed 2010 Mar 1]
    • (2004) Chronic Obstructive Pulmonary Disease
  • 16
    • 0037425745 scopus 로고    scopus 로고
    • Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial
    • DOI 10.1016/S0140-6736(03)12459-2
    • Calverley PM, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361 (9356): 449-56 (Pubitemid 36173708)
    • (2003) Lancet , vol.361 , Issue.9356 , pp. 449-456
    • Calverley, P.1    Pauwels, R.2    Vestbo, J.3    Jones, P.4    Pride, N.5    Gulsvik, A.6    Anderson, J.7    Maden, C.8
  • 17
    • 38449089604 scopus 로고    scopus 로고
    • The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD
    • Cazzola M, Hanania NA. The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1 (4): 345-54
    • (2006) Int J Chron Obstruct Pulmon Dis , vol.1 , Issue.4 , pp. 345-54
    • Cazzola, M.1    Hanania, N.A.2
  • 19
    • 33746879882 scopus 로고    scopus 로고
    • Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids
    • Perng DW, Wu CC, Su KC, et al. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids. Respirology 2006; 11 (5): 598-602
    • (2006) Respirology , vol.11 , Issue.5 , pp. 598-602
    • Perng, D.W.1    Wu, C.C.2    Su, K.C.3
  • 21
    • 70349854706 scopus 로고    scopus 로고
    • Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease
    • Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180 (8): 741-50
    • (2009) Am J Respir Crit Care Med , vol.180 , Issue.8 , pp. 741-50
    • Welte, T.1    Miravitlles, M.2    Hernandez, P.3
  • 22
    • 33747331652 scopus 로고    scopus 로고
    • Australian Bureau of Statistics [online]. Available from URL:
    • Australian Bureau of Statistics. Consumer price index 2010 [online]. Available from URL: http://www.abs.gov.au/ [Accessed 2010 Feb 24]
    • (2010) Consumer Price Index
  • 23
    • 33747331652 scopus 로고    scopus 로고
    • Statistics Sweden [online]. Available from URL:
    • Statistics Sweden. Consumer price index 2010 [online]. Available from URL: http://www.scb.se/Pages/Product-33769.aspx [Accessed 2010 Mar 1]
    • (2010) Consumer Price Index
  • 24
    • 33747331652 scopus 로고    scopus 로고
    • Statistics Canada [online]. Available from URL:
    • Statistics Canada. Consumer price index 2010 [online]. Available from URL: http://www.statcan.gc.ca/subjectssujets/ cpi-ipc/cpi-ipc-eng.htm [Accessed 2010 Mar 1]
    • (2010) Consumer Price Index
  • 25
    • 79955066142 scopus 로고    scopus 로고
    • OECDexchange rate [online].Available fromURL
    • OECDexchange rate [online].Available fromURL: http://stats. oecd.org/index.aspx?queryid=169 [Accessed 2010 Apr 14]
  • 26
    • 79955066999 scopus 로고    scopus 로고
    • Australian Government Department of Health and Ageing. National hospital cost data collection, round 12, 2009 [online]. Available from URL:
    • Australian Government Department of Health and Ageing. National hospital cost data collection, round 12, 2009 [online]. Available from URL: http://www.health.gov.au/ internet/main/publishing.nsf/Content/health-casemix- datacollections- about-NHCDC [Accessed 2010 Mar 1]
  • 28
    • 79955065602 scopus 로고    scopus 로고
    • Unit costs primary care, 2009
    • [online]. Available from URL: DRG codes Sweden [online]. Available from URL: http://www.skane.se/up load/Webb platser/Sod ra%20regionv ardsnamn den/pris lista/ 2009/188-primarv ard-ovr-spec09.pdf [Accessed 2010Mar 1]
    • Swedens municipalities and counties (Sveriges kommuner och landsting), DRG codes Sweden, 2009 [online]. Available from URL: http://www.skl.se/artikel. asp?C=1334&A=41801 [Accessed 2010 Mar 1]
    • (2009) Swedens Municipalities and Counties (Sveriges Kommuner Och Landsting)
    • Södra Regionvårdsnämnden, S.1
  • 29
    • 79955054094 scopus 로고    scopus 로고
    • Australian Government Department of Health and Ageing [online]. Available from URL:
    • Australian Government Department of Health and Ageing. Schedule of pharmaceutical benefits, 2009 [online]. Available from URL: http://www.pbs.gov. au/html/industry/ home [Accessed 2010 Mar 1]
    • (2009) Schedule of Pharmaceutical Benefits
  • 30
    • 79955050879 scopus 로고    scopus 로고
    • The Dental and Pharmaceutical Benefits Agency, TLV [online]. Available from URL:
    • The Dental and Pharmaceutical Benefits Agency, TLV (Tandvård- och Läkemedelsförmånsnämnden), 2009 [online]. Available from URL:http://www.tlv.se/ [Accessed 2010 Mar 1]
    • (2009) Tandvård- Och Läkemedelsförmånsnämnden
  • 32
    • 0030853766 scopus 로고    scopus 로고
    • Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation
    • DOI 10.1002/(SI CI)109 9-1050(199 707)6:4<3 27::AID-HEC 282>3.0.CO;2-W
    • Briggs AH, Wonderling DE, Mooney CZ. Pulling costeffectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997; 6 (4): 327-40 (Pubitemid 27384638)
    • (1997) Health Economics , vol.6 , Issue.4 , pp. 327-340
    • Briggs, A.H.1    Wonderling, D.E.2    Mooney, C.Z.3
  • 33
    • 0034670007 scopus 로고    scopus 로고
    • Use of an angular transformation for ratio estimation in cost-effectiveness analysis
    • Cook JR, Heyse JF. Use of an angular transformation for ratio estimation in cost-effectiveness analysis. Stat Med 2000; 19 (21): 2989-3003
    • (2000) Stat Med , vol.19 , Issue.21 , pp. 2989-3003
    • Cook, J.R.1    Heyse, J.F.2
  • 34
    • 0035061971 scopus 로고    scopus 로고
    • The death of cost-minimization analysis?
    • Briggs AH, OBrien BJ. The death of cost-minimization analysis? Health Econ 2001; 10 (2): 179-84
    • (2001) Health Econ , vol.10 , Issue.2 , pp. 179-84
    • Briggs, A.H.1    Obrien, B.J.2
  • 35
    • 56049123664 scopus 로고    scopus 로고
    • Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD
    • Najafzadeh M, Marra CA, Sadatsafavi M, et al. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD. Thorax 2008; 63 (11): 962-7
    • (2008) Thorax , vol.63 , Issue.11 , pp. 962-7
    • Najafzadeh, M.1    Marra, C.A.2    Sadatsafavi, M.3
  • 36
    • 27744556967 scopus 로고    scopus 로고
    • Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
    • DOI 10.1136/thx.2005.040527
    • Soler-Cataluna JJ, Martinez-GarciaMA, Roman-Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60 (11): 925-31 (Pubitemid 41598207)
    • (2005) Thorax , vol.60 , Issue.11 , pp. 925-931
    • Soler-Cataluna, J.J.1    Martinez-Garcia, M.A.2    Roman Sanchez, P.3    Salcedo, E.4    Navarro, M.5    Ochando, R.6
  • 37
    • 58049090292 scopus 로고    scopus 로고
    • Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD
    • Earnshaw SR, Wilson MR, Dalal AA, et al. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD. Respir Med 2009; 103 (1): 12-21
    • (2009) Respir Med , vol.103 , Issue.1 , pp. 12-21
    • Earnshaw, S.R.1    Wilson, M.R.2    Dalal, A.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.